发明名称 |
1-(6,7-DIFLUORO-3-METHOXYQUINOXALIN-2-YL)-3-[1-(HETEROARYLMETHYL)PIPERIDIN-4-YL] UREA DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESS FOR PREPARATION AND USE THEREOF |
摘要 |
PURPOSE: A 1-(6,7-difluoro-3-methoxyquinoxaline-2-yl)-3-[1-(heteroarylmethyl)piperidine-4-yl]urea derivatives is provided to suppress MCH1R and to prevent and treat obesity without side effects. CONSTITUTION: A 1-(6,7-difluoro-3-methoxyquinoxaline-2-yl)-3-[1-(heteroarylmethyl)piperidine-4-yl]urea derivative is denoted by chemical formula 1. The compound of chemical formula 1 is prepared by reduction alkylation of a compound of chemical formula 5 with heteraryl aldehyde compound of chemical formula 6. A MCH1R inhibitor composition contains the compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. A pharmaceutical composition for preventing and treating obesity contains the compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient.
|
申请公布号 |
KR20110094566(A) |
申请公布日期 |
2011.08.24 |
申请号 |
KR20100014043 |
申请日期 |
2010.02.17 |
申请人 |
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY |
发明人 |
JEON, MOON KOOK;LEE, TAE HO;HWANG, SOON HEE;LEE, JI MIN;YOO, SUNG EUN;LEE, BYUNG HO;OH, KWANG SEOK;GONG, YOUNG DAE;LEE, SUNG HOU |
分类号 |
C07D403/12;A61P3/04;C07D413/14 |
主分类号 |
C07D403/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|